Pulmonary Hypertension Due to Left Heart Disease Clinical Trial
Official title:
Telemonitoring to Treat Group 2 Pulmonary Hypertension: A Personalized Approach
This study aims to decrease elevated pressure in the lungs of patients with pulmonary hypertension from left heart with elevated pulmonary vascular resistance by utilizing aggressive fluid management with ReDS Pro System and CardioMEMS device. Participants with persistently elevated pulmonary pressure at Week 16 will begin oral treprostinil in combination with the fluid management plan while those with improved pressures maintain their fluid management plan for an additional 16 weeks.
This study hypothesizes that monitoring with ReDS-Pro System (ReDS), aggressive fluid management, and the CardioMEMS device (a 3-prong approach) will improve CpcPH (combined pre and post capillary pulmonary hypertension) hemodynamics (Total Pulmonary Resistance [TPR] and mPAP). For patients who continue to have an elevate pulmonary vascular resistance (TPR) at Week 16, with ReDS, aggressive fluid management, and the CardioMEMS device should allow successful titration of oral treprostinil by preventing titration related pulmonary edema and by improving hemodynamics, activity monitoring and six minute walk test (6MWT) after 16 weeks of therapy. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06048120 -
A Study to Learn How Safe the Study Treatment BAY2701250 is, How it Affects the Body and How it Moves Into, Through and Out of the Body in Healthy Male Participants When a Single Amount is Given as an Injection Into the Vein (Intravenous Infusion) or Under the Skin (Subcutaneous Injection)
|
Phase 1 | |
Recruiting |
NCT02164526 -
Registry for Pulmonary Hypertension Due to Left Heart Disease in China
|
N/A | |
Recruiting |
NCT04484675 -
Inhaled and Intravenous Milrinone in Patients With Severe Pulmonary Hypertension
|
Phase 4 | |
Not yet recruiting |
NCT05464238 -
Training in HFpEF-PH
|
N/A | |
Recruiting |
NCT04808596 -
Pulmonary Hypertension Biorepository and Registry
|